Join
Live feed
·
PRReleasevia Quantisnow
Precision BioSciences Inc. logo

Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
DTIL· Precision BioSciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DTIL (Precision BioSciences Inc.) and more on Quantisnow.